ACP-01

N/A

Report date: 2026/04/03 20:03:44

Base Information

Drug NameACP-01
Drug Alias NameEndothelial progenitor cells - HemostemixAngiogenic Cell Precursors - HemostemixVesCellACP-01 (product comprised of autologous angiogenic peripheral blood-derived precursor cells)ACP-01
ClassificationCell and gene therapy > Cell therapy > Source of cells > Angiogenic cells precursors therapyCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Source of cells > Blood-derived
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsIschemiaPeripheral Arterial Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesHungary +[4] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesHemostemix Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTheravitae LtdHemostemix LtdSalus Ltd
Active IndicationsN/A
Inactive IndicationsIschemiaPeripheral Arterial Disease

Other Information

ATC CodeN/A
Related LinksN/A